Actions

AstraZeneca COVID-19 vaccine study paused after one illness

AP2009

Kirsty Wigglesworth/ASSOCIATED PRESS

Reflections are seen in the sign on the global headquarters of Astra Zeneca in London, Thursday, Jan. 29, 2009. Pharmaceuticals company AstraZeneca PLC on Thursday reported a small drop in fourth-quarter net income and said it would cut a further 6,000 jobs globally by 2013 as it looks to shore up its earnings. (AP Photo/Kirsty Wigglesworth)

AstraZeneca COVID-19 vaccine study paused after one illness

By: The Associated Press

Posted at 3:58 PM, Sep 08, 2020

and last updated 2020-09-08 18:58:47-04

Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a patient had a serious side effect linked to the shot. In a statement issued Tuesday evening, the company said it was pausing vaccinations to look into “a potentially unexplained illness," to see if the link is real or a coincidence.

Temporary halts in medical studies aren't uncommon.

Two other vaccines are in huge, final-stage tests in the United States. One is made by Moderna and the other by Pfizer and Germany’s BioNTech.

Actions

AstraZeneca COVID-19 vaccine study paused after one illness

Sign up for the Headlines Newsletter and receive up to date information.

now signed up to receive the Headlines Newsletter.

Congrats to Grads